Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Gordon R. Bernard(Vanderbilt University), Charles J. Fisher, Pierre‐François Laterre(Cliniques Universitaires Saint-Luc), E. Wesley Ely(Geriatric Research Education and Clinical Center), Steven P. LaRosa(Eli Lilly (United States)), Jay S. Steingrub(Tufts University), Jean-François Dhainaut(Université Paris Cité), Jeffrey D. Helterbrand, Jean‐Louis Vincent(Université Libre de Bruxelles), Angel Lopez-Rodriguez, Gary E. Garber(University of Ottawa)
Cited by 6,149
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k